eBook
SEP 16, 2025 6:41 AM PDT

New eBook on the global antimicrobial resistance crisis

SPONSORED BY: Thermo Fisher Scientific
You don't want to miss this!
To permanently access this eBook for free, fill out the short form below.
Unlock eBook
ALREADY ACCESSED THIS eBook? SIGN IN

Antimicrobial resistance (AMR) is no longer a distant threat—it’s a pressing global health crisis already reshaping the way we fight infections. Across hospitals worldwide, pathogens are outpacing conventional treatments, turning once-manageable infections into life-threatening challenges. Multidrug-resistant organisms (MDROs) and healthcare-associated infections (HAIs) are no longer rare exceptions; they’re part of a troubling new normal that places patients at higher risk of severe outcomes, longer hospital stays, and increased healthcare costs.

The implications are staggering. By 2050, AMR could cause up to 10 million deaths annually and burden the global economy with costs reaching $100 trillion. Resistant pathogens like MRSA, CRAB, and Candida auris already strain healthcare systems by driving extended hospitalizations and ICU admissions. Left unchecked, even routine medical procedures or minor injuries could carry serious risks.

Yet, this challenge also presents an opportunity. With advances in diagnostics, antimicrobial susceptibility testing (AST), and novel treatment options, healthcare professionals can stay ahead of evolving threats. The stakes are high, but innovation and proactive strategies can turn the tide.

Download our free eBook to explore how new solutions are helping the medical community combat AMR and safeguard patient care.


You May Also Like
Loading Comments...